Alan Cohen has built companies, sold companies, started a price war between tech giants and now invests in what he calls “tech med” at DCVC, a $4.5bn deep-tech fund.

The distinction matters: tech med starts with data and computational methods, not hardware.

In this conversation, Alan unpacks the investments that excite him, from real-time surgical guidance to AI-powered ultrasound and the pitches that don’t make the cut.

He and Henry dig into hospital bottlenecks, the promise and peril of Health GPT, and his vision for a future where every treatment is personalised to a “circle of one.”